Managing Side Effects Clinical experience with GLP-1 agonists has established several strategies for minimizing gastrointestinal side effects: Slow Titration: Increasing doses gradually over weeks allows the body to adapt
Abbreviations [Ca 2+ ] i : Intracellular Ca 2+ concentration ER: Endoplasmic reticulum GCG: Glucagon GCGR: Glucagon receptor GIP: Glucose-dependent insulinotropic polypeptide GIPR: Glucose-dependent insulinotropic polypeptide receptor GLP-1: Glucagon-like peptide-1 GLP-1R: Glucagon-like peptide-1 receptor GSIS: Glucose-stimulated insulin secretion HFD: High-fat diet LFD: Normal chow diet KO: Knockout nt: Nucleotide PKC: Protein kinase C PLC: Phospholipase C TPPO: Triphenylphosphine oxide TRPM5: Transient receptor potential melastatin 5 WT: Wild-type References Finan B, Yang B, Ottaway N et al (2015) A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents

The Next Frontier: Smart Devices, Digital Integration, and the Coming Patent Wave Connected Inhalers and Dose Tracking GSKs ELLIPTA inhaler line and Tevas Digihaler both incorporate electronics: dose counters, electronic sensors tracking when doses are taken, and Bluetooth connectivity for data transmission to companion apps
Jak diagnozuje si otyo
A low-carbohydrate or ketogenic diet can be beneficial for blood glucose management in type 2 diabetes, and is supported by Diabetes UK and NICE guideline NG28
Tirzepatide: Even more effective than Semaglutide, with clinical trials showing a weight loss of 20% or more in many patients